Replies to post #393976 on Amarin Corp Plc (AMRN)

[studythosestocks]

Thx Raf. Holding steady still.

[couldbebetter]

Getting a bit better...Thanks Raf!

[Number sleven]

Raf, Thanks for the numbers.
Sleven,

[rafunrafun]

Scripts for week ending November 18, 2022

Drug Industry TRx: +0.5% w/w; +7.8% y/y

Vascepa
TRx 63,877; +1.2% (+728) w/w; -18.9% y/y
NRx 29,685; +3.2% (+919) w/w; -16.2% y/y
Ref 34,192; -0.6% (-191) w/w; -21.1% y/y

Fake Vascepa
TRx 42,446; +1.2% (+486) w/w; As % of total V: 39.9%
NRx 20,281; +2.2% (+431) w/w; As % of total V: 40.6%
Ref 22,165; +0.2% (+54) w/w; As % of total V: 39.3%

Fake Vascepa by Manufacturer
Hikma - TRx 15,107; +117 w/w; Generic share 35.6%; Total V share 14.2%
Reddy - TRx 19,245; +102 w/w; Generic share 45.3%; Total V share 18.1%
Apotex - TRx 7,890; +249 w/w; Generic share 18.6%; Total V share 7.4%
Teva - TRx 204; +17 w/w; Generic share 0.5%; Total V share 0.2%

Vascepa + Fake Vascepa
TRx 106,323; +1.2% (+1,214) w/w; +5.7% y/y
NRx 49,966; +2.8% (+1,351) w/w; +5.1% y/y
Ref 56,357; -0.2% (-137) w/w; +6.3% y/y

Lovaza (Fake & Brand)
TRx 63,877; +0.5% (+321) w/w; +0.6% y/y
NRx 31,008; -0.3% (-84) w/w; -0.3% y/y
Ref 32,868; +1.2% (+405) w/w; +1.6% y/y